Dimensional Fund Advisors
BIOC

Dimensional Fund Advisors’s Biocept, Inc. BIOC Stock Holding History

Dimensional Fund Advisors’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-428
Closed -$12K – 3533
2022
Q3 		$12K Hold
428
– – ﹤0.01% 3483
2022
Q2 		$12K Sell
428
-882
-67% -$40.2K ﹤0.01% 3456
2022
Q1 		$91K Sell
1,310
-158
-11% -$12.4K ﹤0.01% 3402
2021
Q4 		$159K Buy
+1,468
New +$169K ﹤0.01% 3376
2019
Q2 		– Sell
-212
Closed -$73K – 3481
2019
Q1 		$73K Sell
212
-156
-42% -$63.2K ﹤0.01% 3395
2018
Q4 		$95K Buy
368
+237
+181% +$119K ﹤0.01% 3362
2018
Q3 		$108K Buy
+131
New +$167K ﹤0.01% 3352

Other funds holding BIOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TMWM
Taylor & Morgan Wealth Management Flint, Michigan $203M AUM 24.74% 1-Year Est. Return

Dimensional Fund Advisors's BIOC Position: Q4 2022 in Review

Dimensional Fund Advisors sold out of Biocept, Inc. (BIOC) in Q4 2022, closing a stake of 428 shares — an estimated $12K sold.

Dimensional Fund Advisors first reported a position in BIOC in Q3 2018 and held it in 7 quarters. The position peaked at $159K in Q4 2021. 25 funds tracked by Wall St. Rank hold BIOC as of Q4 2022.

  • Dimensional Fund Advisors reported no remaining Biocept, Inc. position as of Q4 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 428 Biocept, Inc. shares in Q4 2022, an estimated $12K.
  • Dimensional Fund Advisors first reported a position in Biocept, Inc. in Q3 2018 and held it in 7 quarters.
  • Dimensional Fund Advisors's Biocept, Inc. position peaked at $159K in Q4 2021.
  • 25 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2022.

Based on Dimensional Fund Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.